Recro Pharma's GAAP loss for 2021 was $11.37 million, down 2.6 times from $27.501 million in the previous year. Revenue increased 13.3% to $75.36 million from $66.499 million a year earlier.
Recro Pharma's GAAP loss for 2021 was $11.37 million, down 2.6 times from $27.501 million in the previous year. Revenue increased 13.3% to $75.36 million from $66.499 million a year earlier. 
ir.recropharma.com
English (US) 